Qingdao Haier Biomedical Co., Ltd. (688139.SH): The actual controller and the concerted action persons collectively increased their holdings by 1.06%.
Haier BioMed (688139.SH) announced that Qingdao, the controlling shareholder of the company Haier group corporation, the consistent action.
Qingdao Haier Biomedical Co., Ltd. (688139.SH) announced that Qingdao Haichuangzhi Management Consulting Enterprise (Limited Partnership) (referred to as "Haichuangzhi"), a concerted action person of the actual controller Haier Group Corporation, increased its holdings by a total of 3.3731 million shares from January 10, 2025 to February 25, 2025, representing 1.06% of the total shares.
Related Articles
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
